Medtech Insight and Windhover Information's 2006 ``Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies''; International Biotech Investing, Business Development the Focus of Premier Informational & Networking Event.NORWALK, Conn. -- September 18-20, 2006 Crowne Plaza, Brussels City Centre, Belgium The 2006 "Investment in Innovation (In3) Europe: A Preview of Emerging Technologies," sponsored by Medtech Insight, a division of Windhover Information, has set a groundbreaking agenda for the Sept. 18-20 conference. In3 Europe is the industry's most efficient strategic partnering and investment meeting for the international medtech development community. The audience will be comprised of hundreds of senior-level decision-makers from most of the major medtech companies and healthcare investment firms worldwide, representing most of the major dealmakers in the medical technology industry. Dynamic agenda planned for conference In addition to its premier opportunities for networking and partnering throughout the event, In3 Europe will feature a number of eminent healthcare executives as speakers and an in-depth industry panel discussion. The agenda includes: --"Best Practices for Venture Investing venture investing The acquiring of a stake in a start-up company by a brokerage firm or analyst by obtaining discounted, pre-IPO shares. Critics claim venture investing causes analysts to have a vested interest in seeing a stock appreciate in value and so in Europe" with Michel Lussier, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of MedPole, Chairman of Cardio3 and VP & General Manager of European Operations for Volcano --"Medtech Investing in Europe: the 3i Perspective" with Andrew Fraser, Partner, 3i --"The European Route: First CE-mark and then FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval; does it make sense?" with Dirk Meijer, M.D., Ph.D., CEO, Factory CRO --"What Makes Israel Such a Dynamic Device Company Developer?" with Zev Zehavi, Johnson & Johnson Development Corporation, and David Cassak, Managing Partner, Windhover Information, as moderator Lussier founded MedPole SA/NV in March 2002, a European incubator for medical device start-up companies. During its first years of operation, MedPole has enabled the early European development of a number of US, Israeli, and European high-technology medical device companies, including Cardio3 SA, a start-up cell therapy company dedicated to cell transplant solutions for cardiovascular applications. Fraser has 12 years of experience in venture capital in life sciences, and specializes in investing in medical devices and pharmaceuticals companies. Notable recent investments include Endosense, Novexel and Carmel Pharma. Dr. Meijer has more than 15 years of experience in the design of clinical trials and analysis of European regulatory affairs for medical devices, and has published numerous articles in medical journals and has given many presentations to professional societies. More than 50 companies to present Emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership opportunities are schedule to present at the conference. The current list of presenters includes: --ABMI, Lausanne, Switzerland -- expert systems and miniaturized hardware for stroke prevention and management and for pre-operative brain protection --AION Diagnostics, Perth, Australia -- diagnostic applications for BioSilicon platform technology --Arbel Medical, Yokneam, Israel --technological platform for the next generation of minimally invasive cryosurgical treatments --BioImagene, Cupertino, CA -- analyze, search, store, mine, share and unlock the power of digital tissue images --Biosan Medical, Rishon Le'Zion, Israel -- surgical device/method for the treatment of stroke/subarachnoid and intraventricular hemorrhages of different etiologies --Card Guard Scientific Survival, Rehovot, Israel -- embedded medical and wellness applications in wireless and cellular platforms --Cardio3, Braine L'Alleud, Belgium -- a process for stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. selective differentiation and transplantation in heart failure patients --Cheetah Medical, Ra'anana, Israel -- NICOM(TM), a continuous, noninvasive hemodynamic monitoring hemodynamic monitoring Clinical medicine A general term for the ongoing evaluation of hemodynamics that delivers accurate results, sensor placement flexibility, and motion tolerance --Diagnostic Devices, Simsbury, CT -- accurate and efficient identification of human Embryonic Stem Cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. using Signal Characteristic Analysis (hE(SC)2AN) --Dialog Devices, Leicestershire, UK - PADD PADD Personal Access Display Device (Star Trek) PADD Person Authorized to Direct Disposition (of human remains) PADD Parallel and Distributed Databases PADD Protection and Advocacy for Developmental Disabilities for noninvasive screening of peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. , combining postural and infrared blood volume testing --EMcision, London, UK -- medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant --Innovate, Manchester, UK -- flexible safety system protecting healthcare workers from needle-stick injury, allowing separated disposal of sharps/waste --InspireMD, Tel Aviv, Israel -- a micron level sleeve which wraps stents to seamlessly block embolic embolic /em·bol·ic/ (em-bol´ik) pertaining to an embolus or to embolism. em·bol·ic adj. 1. Relating to, or caused by an embolus or embolism. 2. Relating to emboly. showers without affecting deliverability --Lapeyre Industries, Eysines, France - technology description available soon --LiverCyte, London, UK -- technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue --Morris Innovative Research, Bloomington, IN - vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing sheath with pre-mounted re-absorbable closure device --Novashunt, Saratoga, CA -- automated implantable pump implantable pump Therapeutics A device installed under the skin to administer a steady dose of drugs systems for moving fluids around inside the body --OZ Recovery Technologies, Ramat Gan, Israel -- a medical device for wound therapy using controlled ozone and oxygen mixtures --PreSRV, Yokneam, Israel -- an implant preserving the femoral femoral /fem·o·ral/ (fem´or-al) pertaining to the femur or to the thigh. fem·o·ral adj. Of or relating to the femur or thigh. head and cartilage in patients with displaced femoral neck fractures --Protomed, Marseille, France -- minimally invasive instruments and implants to improve outcomes of laparoscopic Laparoscopic A minimally-invasive surgical or diagnostic procedure that uses a flexible endoscope (laparoscope) to view and operate on structures in the abdomen. Mentioned in: Obstetrical Emergencies vascular surgery --Provista Life Sciences, Phoenix, AZ -- noninvasive diagnostic technologies for the early detection of estrogen associated cancers and Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. --Stentys, Paris, France -- bifurcated bi·fur·cate v. bi·fur·cat·ed, bi·fur·cat·ing, bi·fur·cates v.tr. To divide into two parts or branches. v.intr. To separate into two parts or branches; fork. adj. coronary stent coronary stent Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent --SutureAid, Andover, MA -- technology description available soon --Tibion, Moffett Field, CA -- active orthotic orthotic /or·thot·ic/ (or-thot´ik) serving to protect or to restore or improve function; pertaining to the use or application of an orthosis. or·thot·ic adj. Of or relating to orthotics. devices - programmable, sensor-driven muscle assistance, resistance, and robotic therapy for the mobility impaired --Triage Medical, Irvine, CA -- minimally invasive dynamic stabilization device --Victhom Human Bionics, Quebec, Canada -- Implantable Closed Loop System device (neuromodulation, neurosensing, neurostimulation), restoring gait for lost mobility (i.e. stroke patients) --WideMed, Herzliya, Israel -- disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker The forum will provide focused overviews by a senior executive from each presenting company, followed by the opportunity to meet one-on-one in private breakout rooms. Co-sponsors for In3 Europe include 3i, Battelle, Business Wire, Factory, Medical Capital Advisers, Ronald Trahan Associates and T for G. Registrations now being accepted Windhover is now accepting registrations for the event, which will be held Sept. 18-20 in Brussels, Belgium. Medtech Insight's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past five years. Participating companies send multiple attendees, including company presidents, CEOs, partners, and VPs for business development, marketing, acquisitions, corporate development and R&D. Past attending companies have included 3M, AG Edwards, Arthur Andersen, Bayer, Boston Scientific, The Cleveland Clinic Foundation, C.R. Bard, Cordis, Edwards Lifesciences, Eli Lilly, Ernst & Young, FibroGen, Glaxo Smith Kline, The Gray Sheet, Guidant, Hologic Inc., Integra Life Sciences. Johnson & Johnson, Karolinska Investment Fund, Kimberly-Clark, Krauth Medical, Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , Medtronic, Morgan Stanley, NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on , Novartis, Procter & Gamble, Smith & Nephew, Stryker, Tenex, Yale University School of Medicine, and ZEVEX International. To register, call Kristy Grimes of Medtech Insight at 480-985-9512, or 888-202-5939 toll-free in the U.S.; e-mail kristy@medtechinsight.com; or register on the In3 Medical Device Summit website at www.meddevicesummit.com. About Medtech Insight Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion